Analysis of exposure-response relationship in everolimus-cyclosporine combination regimen.
Lee
Jang-Ik
JI
Tracy
Laree
L
Higgins
Karen
K
Hernandez
Arturo
A
Cavaille-Coll
Marc
M
D019540:Area Under Curve; D003404:Creatinine / Q000097:blood; D016903:Drug Monitoring / Q000379:methods; D004359:Drug Therapy, Combination; D000068338:Everolimus; D005919:Glomerular Filtration Rate; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D008657:Metabolic Clearance Rate; D020123:Sirolimus / Q000008:administration & dosage* / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D013997:Time Factors; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D000068338:Everolimus; D003404:Creatinine; D020123:Sirolimus